Director’s Major Stock Sale Shakes Up Precigen!

New insider activity at Precigen ( (PGEN) ) has taken place on December 16, 2025.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential Director Jeffrey Kindler has made a significant move by selling 235,467 shares of Precigen stock, amounting to a total transaction value of $854,745. This sale marks a notable shift in the director’s holdings in the company. Recent Updates on PGEN stock In the last 24 hours, Precigen’s stock has experienced notable developments, primarily driven by its recent earnings report and the launch of its product, Papzimeos. The company’s optimistic earnings call highlighted the success of Papzimeos, which has been a significant factor in the raised price target by analysts. The price target adjustment reflects the positive market reception and anticipated demand for Papzimeos. Additionally, Precigen reported a substantial improvement in its Q3 earnings per share compared to the previous year, further supporting the upward revision in the stock’s price target. These developments underscore the company’s strong performance and growth potential, contributing to the positive sentiment among investors. Spark’s Take on PGEN Stock According to Spark, TipRanks’ AI Analyst, PGEN is a Neutral. Precigen’s overall stock score is primarily impacted by its weak financial performance and challenging valuation. However, the optimistic outlook from the earnings call, driven by the approval and deployment of Papcemias, provides a potential catalyst for future growth. Technical indicators suggest bearish momentum, but potential oversold conditions could offer a buying opportunity for risk-tolerant investors. To see Spark’s full report on PGEN stock, click here. More about Precigen YTD Price Performance: 252.78% Average Trading Volume: 4,705,795 Technical Sentiment Signal: Buy Current Market Cap: $1.31B